M. M. R. F. Struys, M. Sahinovic, B. J. Lichtenbelt, H. E. M

Slides:



Advertisements
Similar presentations
Advances in the Clinical Pharmacology of Intravenous Anesthetics : Pharmacokinetic, Pharmacodynamic, Pharmaceutical, and Technological Considerations R3.
Advertisements

Serotonin syndrome manifesting as patient movement during total intravenous anesthesia with propofol and remifentanil  Jennifer J. Davis, MD, Nathan S.
Influence of anaesthesia and analgesia on the control of breathing
Concentration-dependent suppression of F-waves by sevoflurane does not predict immobility to painful stimuli in humans†  J.H. Baars, D. Kalisch, K.F.
Comparison of continuous non-invasive finger arterial pressure monitoring with conventional intermittent automated arm arterial pressure measurement in.
T. Tedore  British Journal of Anaesthesia 
Relationship between Bispectral Index, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints  M. Iannuzzi,
Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the World.
The effects of i.v. fentanyl administration on the minimum alveolar concentration of isoflurane in horses  Thomasy S.M. , Steffey E.P. , Mama K.R. , Solano.
Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia  M Hara, K Masui, D.J. Eleveld,
Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal brain tumours and control patients  M.M.
Intravenous lidocaine infusion reduces bispectral index-guided requirements of propofol only during surgical stimulation†   G.A. Hans, S.M. Lauwick, A.
M. M. Sahinovic, D. J. Eleveld, T Miyabe-Nishiwaki, M. M. R. F
AnestAssist British Journal of Anaesthesia
Supplemental oxygen and surgical site infection: getting to the truth
Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial† ‡   N Goettel, S Bharadwaj,
Stimulation induced variability of pulse plethysmography does not discriminate responsiveness to intubation  M Luginbu¨hl, M Ru¨fenacht, I Korhonen, M.
In vivo characterization of clinical anaesthesia and its components
Pharmacokinetic and pharmacodynamic interactions in anaesthesia
Explaining Entropy responses after a noxious stimulus, with or without neuromuscular blocking agents, by means of the raw electroencephalographic and.
Enhancing a sedation score to include truly noxious stimulation: the Extended Observer's Assessment of Alertness and Sedation (EOAA/S)  T.K. Kim, P.J.
A.R. Absalom, V. Mani, T. De Smet, M.M.R. F. Struys 
Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: performance of three.
A different use of visual analytic techniques in anaesthetics
Bruhn J , Myles P.S. , Sneyd R , Struys M.M.R.F.  
Thoracic epidural analgesia or patient-controlled local analgesia for radical retropubic prostatectomy: a randomized, double-blind study  F. Fant, K.
S. Kreuer, J. Bruhn, R. Larsen, M. Hoepstein, W. Wilhelm 
L. I. Cortínez, B. J. Anderson, A Penna, L Olivares, H. R. Muñoz, N. H
Dexmedetomidine pharmacodynamics in healthy volunteers: 2
Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children  C. Jeleazcov, H. Ihmsen,
Chronic opioid therapy for non-cancer pain
Monitoring and delivery of sedation
Validation of the index of consciousness during sevoflurane and remifentanil anaesthesia: a comparison with the bispectral index and the cerebral state.
Spectral entropy measurement of patient responsiveness during propofol and remifentanil. A comparison with the bispectral index†  Vanluchene A.L.G. ,
Evaluation of the effect of intravenous lidocaine on propofol requirements during total intravenous anaesthesia as measured by bispectral index†  F.R.
Detection of awareness in surgical patients with EEG-based indices—bispectral index and patient state index†‡  G. Schneider, A.W. Gelb, B. Schmeller,
Interaction of physostigmine and alfentanil in a human pain model†
EEG-controlled closed-loop dosing of propofol in rats
Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol–remifentanil anaesthesia  M. Gruenewald, C. Ilies, J. Herz,
Dexmedetomidine pharmacokinetic–pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation  P.J. Colin,
Pharmacodynamic response modelling of arterial blood pressure in adult volunteers during propofol anaesthesia  C. Jeleazcov, M. Lavielle, J. Schüttler,
Does bispectral analysis add anything but complexity
Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded.
Postoperative intravenous morphine titration
G. Park, M. Lane, S. Rogers, P. Bassett  British Journal of Anaesthesia 
Keira P. Mason, Neena Seth  British Journal of Anaesthesia 
Patient state index vs bispectral index as measures of the electroencephalographic effects of propofol  M Soehle, M Kuech, M Grube, S Wirz, S Kreuer,
Bispectral index is related to the spread of spinal sensory block in patients with combined spinal and general anaesthesia  R Iida, K Iwasaki, J Kato,
Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an ‘inhalation bolus’ technique  L.E.C. De Baerdemaeker,
Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under.
Nervus medianus evoked potentials and bispectral index during repeated transitions from consciousness to unconsciousness†  I. Rundshagen, J. Mast, N.
Do old pharmacokinetic parameter estimates predict new data?
H.M. Soliman, C. Mélot, J.-L. Vincent  British Journal of Anaesthesia 
B. Rehberg, N. Wickboldt, C. Juillet, G. Savoldelli 
Some heightened sensitivity
Effect of propofol and sevoflurane on coughing in smokers and non-smokers awakening from general anaesthesia at the end of a cervical spine surgery  P.
Remifentanil–sevoflurane interaction models of circulatory response to laryngoscopy and circulatory depression  S.S. Bi, C.H. Deng, T.Y. Zhou, Z. Guan,
Performance of electroencephalogram-derived parameters in prediction of depth of anaesthesia in a rabbit model  A. Silva, D.A. Ferreira, C. Venâncio,
NAP5: the tip of the iceberg, or all we need to know?
Sufentanil administration guided by surgical pleth index vs standard practice during sevoflurane anaesthesia: a randomized controlled pilot study†  M.
Comparative clinical effects of hydromorphone and morphine: a meta-analysis  L. Felden, C. Walter, S. Harder, R.-D. Treede, H. Kayser, D. Drover, G. Geisslinger,
Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of.
Relationship between Bispectral Index, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints  M. Iannuzzi,
Skin conductance monitoring compared with bispectral index® monitoring to assess emergence from general anaesthesia using sevoflurane and remifentanil 
Effectiveness of electroacupuncture analgesia compared with opioid administration in a dog model: a pilot study  D. Groppetti, A.M. Pecile, P. Sacerdote,
Analgesia for day-case surgery†
The suppression of spinal F-waves by propofol does not predict immobility to painful stimuli in humans†  J.H. Baars, S Tas, K.F. Herold, D.A. Hadzidiakos,
Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose-finding study  B. Steinlechner, M. Dworschak, B.
Closed-loop control of propofol anaesthesia using bispectral index™: performance assessment in patients receiving computer-controlled propofol and manually.
Analysis of pharmacodynamic interaction of sevoflurane and propofol on bispectral index during general anaesthesia using a response surface model  J.C.
Presentation transcript:

Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts  M.M.R.F. Struys, M. Sahinovic, B.J. Lichtenbelt, H.E.M. Vereecke, A.R. Absalom  British Journal of Anaesthesia  Volume 107, Issue 1, Pages 38-47 (July 2011) DOI: 10.1093/bja/aer108 Copyright © 2011 The Author(s) Terms and Conditions

Fig 1 Dose–response relationships and interaction between hypnotics and analgesics. (Reprinted with permission from Sahinovic and colleagues.)8 The green areas represent the kinetic process. The pink areas represent the relationship between the effect-site concentration and effect. Both pharmacokinetic and pharmacodynamic interactions are shown. Feedback control is shown for both hypnotics and analgesics, taking the interactions into account. British Journal of Anaesthesia 2011 107, 38-47DOI: (10.1093/bja/aer108) Copyright © 2011 The Author(s) Terms and Conditions

Fig 2 Dose–response relationship for one drug. Pharmacokinetics are depicted as a multicompartmental model. Pharmacodynamics are shown as a sigmoidal Emax model. Kinetics and dynamics are linked by an effect-site compartment. (Modified from Absalom and Struys96 with permission.) British Journal of Anaesthesia 2011 107, 38-47DOI: (10.1093/bja/aer108) Copyright © 2011 The Author(s) Terms and Conditions

Fig 3 Smart Pilot View (Dräger, Lübeck, Germany). This display represents a balanced anaesthetic case using a volatile agent, propofol, remifentanil, and fentanyl. It uses a topographical plot of the interaction between hypnotic and analgesic drugs (left plot) and represents the vital signs and bispectral index scale (BIS), dose and effect over time. Furthermore, it introduces the noxious stimulus response index (NSRI) as a new parameter (right plots). The topographical plot on the left illustrates the synergistic interaction of hypnotic and analgesic drugs with grey-scaled isoboles. MAC 50 and 90 indicate the probability of loss of response to skin incision (MAC, minimum alveolar concentration). MAC awake indicates the probability of wake-up. Fentanyl is converted into remifentanil equivalents, so its contribution can be accounted for on the isobole plot. The plots on the lower right represent the time course for each drug over the previous 40 min to 4 h and 20 min into the future. A series of symbols (light green buttons) are used as Event Markers during a surgical procedure (e.g. loss of consciousness, intubation, and incision). These are useful to mark the individual reaction or non-reaction of the patient and determine if the patient’s individual reaction corresponds to the level of anaesthesia, which is represented by the isoboles calculated from the behind lying algorithms. (SmartPilot® View, reprinted with permission, © Dräger Medical GmbH, Lübeck, Germany.) British Journal of Anaesthesia 2011 107, 38-47DOI: (10.1093/bja/aer108) Copyright © 2011 The Author(s) Terms and Conditions

Fig 4 The Navigator Therapy (GE Healthcare, Helsinki, Finland) display provides a tool for modelling and visualization of PK/PD models for common anaesthetic (inhaled and i.v.) drugs. In addition, it provides a model for the synergistic effects of propofol (or inhaled agents) and the fentanyl family. The calculated effect-site concentrations are displayed in a time-based graphical format. The total effect trace (the black line shown in the sedation and analgesia windows) visualizes the combined synergistic effect of the analgesic and sedative drugs. The displayed effects include level of sedation according to loss of consciousness probability, level of analgesia according to the probability of response to intubation (high pain stimuli), and level of neuromuscular block. The drug models are calculated for up to 1 h into the future providing predictive drug modelling for drug concentration and quantifying complex drug interactions. (Navigator Therapy display, reprinted with permission, © 2010 General Electric Company, Helsinki, Finland.) British Journal of Anaesthesia 2011 107, 38-47DOI: (10.1093/bja/aer108) Copyright © 2011 The Author(s) Terms and Conditions